These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1330221)

  • 1. [Chemoprophylaxis and chemotherapy of common colds caused by rhinoviruses: overview and outlook].
    Werner GH
    Bull Acad Natl Med; 1992 May; 176(5):669-81. PubMed ID: 1330221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on the nasal mucosa of upper respiratory viruses (common cold).
    Winther B
    Dan Med Bull; 1994 Apr; 41(2):193-204. PubMed ID: 8039434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virucidal hand treatments for prevention of rhinovirus infection.
    Turner RB; Hendley JO
    J Antimicrob Chemother; 2005 Nov; 56(5):805-7. PubMed ID: 16159927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virology and immunology of the common cold.
    Gwaltney JM
    Rhinology; 1985 Dec; 23(4):265-71. PubMed ID: 3001912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhinoviruses and coronaviruses - virological aspects of their role in causing colds in man.
    Tyrrell DA
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():332-5. PubMed ID: 6311602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding human rhinovirus infections in terms of QSAR.
    Verma RP; Hansch C
    Virology; 2007 Mar; 359(1):152-61. PubMed ID: 17045322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the pathophysiology of rhinovirus upper respiratory tract infections.
    van Kempen M; Bachert C; Van Cauwenberge P
    Rhinology; 1999 Sep; 37(3):97-103. PubMed ID: 10567986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iota-Carrageenan is a potent inhibitor of rhinovirus infection.
    Grassauer A; Weinmuellner R; Meier C; Pretsch A; Prieschl-Grassauer E; Unger H
    Virol J; 2008 Sep; 5():107. PubMed ID: 18817582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds.
    Turner RB
    Clin Infect Dis; 2001 Dec; 33(11):1865-70. PubMed ID: 11692298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis.
    Schoop R; Klein P; Suter A; Johnston SL
    Clin Ther; 2006 Feb; 28(2):174-83. PubMed ID: 16678640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A view from the Common Cold Unit.
    Tyrrell DA
    Antiviral Res; 1992 Jun; 18(2):105-25. PubMed ID: 1329647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.
    Fan SY; Zheng ZB; Mi CL; Zhou XB; Yan H; Gong ZH; Li S
    Bioorg Med Chem; 2009 Jan; 17(2):621-4. PubMed ID: 19091578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection.
    Marlin SD; Staunton DE; Springer TA; Stratowa C; Sommergruber W; Merluzzi VJ
    Nature; 1990 Mar; 344(6261):70-2. PubMed ID: 1968231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhinovirus and coronavirus infections.
    Greenberg SB
    Semin Respir Crit Care Med; 2007 Apr; 28(2):182-92. PubMed ID: 17458772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers.
    Zerial A; Werner GH; Phillpotts RJ; Willmann JS; Higgins PG; Tyrrell DA
    Antimicrob Agents Chemother; 1985 May; 27(5):846-50. PubMed ID: 2990329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission and control of rhinovirus colds.
    Jennings LC; Dick EC
    Eur J Epidemiol; 1987 Dec; 3(4):327-35. PubMed ID: 2446913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of organic acids in hand cleansers for prevention of rhinovirus infections.
    Turner RB; Biedermann KA; Morgan JM; Keswick B; Ertel KD; Barker MF
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2595-8. PubMed ID: 15215114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of rhinovirus infection in vitro by IL-8, HuIFN-alpha, and TNF-alpha.
    Berg K; Andersen H; Owen TC
    APMIS; 2004 Mar; 112(3):172-82. PubMed ID: 15153159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in rhinovirus therapeutics.
    Charles CH; Yelmene M; Luo GX
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):331-7. PubMed ID: 15578974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.